25 years of experience in academic research in plant biology and pharmacology and 5 years of experience in industrial research in plant biotechnology. Dr. Raskin joined the faculty of the Biotechnology Center for Agriculture and the Environment at Rutgers, The State University of New Jersey, in 1989. As Professor II of Plant Sciences, he directs scientific programs composed of over 50 researchers from more than 15 different countries. He also serves as Chairman of the Board of Phytomedics Inc., a successful botanical therapeutics company; Director of the NIH-NSF-USDA-funded biodiversity and pharmacological discovery program (ICBG) in Central Asia; Associate Director of the NIH Botanical Center for Metabolic Syndrome; and Academic Director and Founder of Global Institute for Bio-Exploration (GIBEX).
Dr. Raskin achieved an international reputation through his work on salicylic acid, phytoremediation and, in the last decade, for his research in plant-derived therapeutics, molecular farming, and biodiversity. Dr. Raskin’s research is featured in over 120 major scientific publications and in frequent popular press articles. Among his most cited scientific publications are four cover articles in Science and Nature. Dr. Raskin was also awarded 18 patents covering the discoveries made in his laboratory. Dr. Raskin has received numerous prestigious awards, including the Albert Shull Award for outstanding contributions to plant biology and Thomas Alva Edison Patent Awards for revolutionary product innovations and scientific breakthrough. Dr. Raskin was named the Century Innovator in Botany by the U.S. News & World Report and listed as one of 108 most cited researchers in Plant and Animal Science ( Institute of Scientific Information).